PATENT CLAIM ANALYSIS

Application Number: 16158527
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["546", "085000"]

Abstract:
The invention concerns compounds of Formula (I) or pharmaceutically-acceptable salts thereof, wherein R 1  to R 5  have any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of cell proliferative disorders.

Claim (Index 11):
A method according to  claim 10 , wherein the compound of Formula (II) is (E)-methyl 3-(3,5-difluoro-4-((1R,3R)-2-(2-fluoro-2-methylpropyl)-3-methyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl)phenyl)acrylate.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 97.0
- Lexical Diversity: 1.18605
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14287332', '14840342', '15445000', '15657395', '15881962']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8660604737319438
- 35 USC 102 Novelty (BERT): 0.629570665349852
- Combined Prediction Score: 0.8424114928937347
- Mean Citation Score: 556.9531059999998
- Max Citation Score: 628.86176
- Similarity Product: 542.7583981966018

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test